Mount Sinai Hospital, formerly at times known as Mount Sinai Medical Center, is a 319-bed major urban hospital in Chicago, Illinois, with its main campus located adjacent to Douglass Park at 15th Street and California Avenue on the city's West Side.

There are 319 beds in Mount Sinai Hospital Medical Center.

During the past decade, Mount Sinai Hospital Medical Center conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 44 clinical trials were completed, i.e. on average, 125.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 25 clinical trials were completed. i.e. 416.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Sinai Hospital Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai Hospital Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "Canadian Cancer Trials Group" with 4 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai Hospital Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "HIV Infections" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (5 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Mount Sinai Hospital Medical Center" in a lesser frequency.

Most popular intervention types in "Mount Sinai Hospital Medical Center" are "Drug" (67 trials), "Other" (49 trials), "Biological" (36 trials), "Procedure" (15 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Quality-of-Life Assessment" (16 trials), "Paclitaxel" (13 trials), "Docetaxel" (12 trials) and "Bevacizumab" (10 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai Hospital Medical Center" are 62 trials for "All" genders, 21 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Mount Sinai Hospital Medical Center". undefined are not yet recruiting, 6 are recruiting, 36 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Mount Sinai Hospital Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai Hospital Medical Center, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Mount Sinai Hospital Medical Center has several departments that took part in Clinical trials: "Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program" - 9 trials